BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27956096)

  • 21. Cost containment and the backdraft of competition policies.
    Light DW
    Int J Health Serv; 2001; 31(4):681-708. PubMed ID: 11809005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing choices in health care: implications for equity, efficiency and cost.
    Bevan G; Helderman JK; Wilsford D
    Health Econ Policy Law; 2010 Jul; 5(3):251-67. PubMed ID: 20478104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statutory health insurance competition in Europe: a four-country comparison.
    Thomson S; Busse R; Crivelli L; van de Ven W; Van de Voorde C
    Health Policy; 2013 Mar; 109(3):209-25. PubMed ID: 23395277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescribing behavior of general practitioners: competition matters.
    Schaumans C
    Health Policy; 2015 Apr; 119(4):456-63. PubMed ID: 25601184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with hospital closure and merger: a survival analysis of Dutch hospitals from 1978 to 2010.
    den Hartog M; Janssen R; Haselbekke BJ; Croes R; Klik M
    Health Serv Manage Res; 2013 Feb; 26(1):1-8. PubMed ID: 25594996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Medicine Prices in New Zealand and 16 European Countries.
    Vogler S; Kilpatrick K; Babar ZU
    Value Health; 2015 Jun; 18(4):484-92. PubMed ID: 26091603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital mergers: policy implications for consumers.
    Celebrezze AJ
    J State Gov; 1989; 62(3):119-20. PubMed ID: 10294464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health care consolidation and the changing health care marketplace. A review of the literature and issues.
    Goldberg LG
    EBRI Issue Brief; 1999 Oct; (214):1-15. PubMed ID: 10622866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How does managed competition affect hospital prices in a social health insurance system? The Colombian case.
    Fernando R; Leticia AB; Antonio J T
    Health Policy Plan; 2018 Nov; 33(9):1037-1046. PubMed ID: 30462221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imperfect information in a quality-competitive hospital market.
    Gravelle H; Sivey P
    J Health Econ; 2010 Jul; 29(4):524-35. PubMed ID: 20573413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital pricing: cost shifting and competition.
    Morrisey MA
    EBRI Issue Brief; 1993 May; (137):1-17. PubMed ID: 10129621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of regulated competition on key outcomes of care: cataract surgeries in the Netherlands.
    Heijink R; Mosca I; Westert G
    Health Policy; 2013 Nov; 113(1-2):142-50. PubMed ID: 23827262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competition in hospital and health insurance markets: a review and research agenda.
    Morrisey MA
    Health Serv Res; 2001 Apr; 36(1 Pt 2):191-221. PubMed ID: 11327174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do competition and managed care improve quality?
    Sari N
    Health Econ; 2002 Oct; 11(7):571-84. PubMed ID: 12369060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competition or coordination in hospital markets with unionised labour.
    Brekke KR
    Int J Health Care Finance Econ; 2004 Mar; 4(1):65-89. PubMed ID: 15170965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolving science of quality measurement for hospitals: implications for studies of competition and consolidation.
    Romano PS; Mutter R
    Int J Health Care Finance Econ; 2004 Jun; 4(2):131-57. PubMed ID: 15211103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What can Europe learn from the managed care backlash in the United States?
    Duijmelinck D; van de Ven W
    Health Policy; 2016 May; 120(5):509-18. PubMed ID: 27055353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wide variation in hospital and physician payment rates evidence of provider market power.
    Ginsburg PB
    Res Brief; 2010 Nov; (16):1-11. PubMed ID: 21117341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can governments do it better? Merger mania and hospital outcomes in the English NHS.
    Gaynor M; Laudicella M; Propper C
    J Health Econ; 2012 May; 31(3):528-43. PubMed ID: 22634021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.